Braun Stacey Associates’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
BG
Braun Stacey Associates's AGN Position: Q4 2017 in Review
Braun Stacey Associates sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 46,754 shares — an estimated $9.58M sold.
Braun Stacey Associates first reported a position in AGN in Q2 2013 and held it in 17 quarters. The position peaked at $23.4M in Q1 2015. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.
- Braun Stacey Associates reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
- Braun Stacey Associates sold 46,754 Allergan plc shares in Q4 2017, an estimated $9.58M.
- Braun Stacey Associates first reported a position in Allergan plc in Q2 2013 and held it in 17 quarters.
- Braun Stacey Associates's Allergan plc position peaked at $23.4M in Q1 2015.
- 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.
Based on Braun Stacey Associates's 13F filing for Q4 2017, filed 30 Jan 2018.